|
Volumn 20, Issue 6, 2002, Pages 1085-1087
|
Subgroup analysis of the NORDIL trial
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIHYDROPYRIDINE DERIVATIVE;
DILTIAZEM;
DIURETIC AGENT;
NITRENDIPINE;
THIAZIDE DIURETIC AGENT;
ANTIHYPERTENSIVE THERAPY;
CLINICAL TRIAL;
DRUG EFFICACY;
HEART INFARCTION;
HUMAN;
HYPERTENSION;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
RISK;
SHORT SURVEY;
STROKE;
CEREBROVASCULAR ACCIDENT;
CONTROLLED CLINICAL TRIAL;
NOTE;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
TREATMENT OUTCOME;
CALCIUM CHANNEL BLOCKERS;
CEREBROVASCULAR ACCIDENT;
DILTIAZEM;
HUMANS;
HYPERTENSION;
MYOCARDIAL INFARCTION;
RANDOMIZED CONTROLLED TRIALS;
RISK FACTORS;
TREATMENT OUTCOME;
|
EID: 0036591585
PISSN: 02636352
EISSN: None
Source Type: Journal
DOI: 10.1097/00004872-200206000-00018 Document Type: Short Survey |
Times cited : (1)
|
References (9)
|